vs
Side-by-side financial comparison of CPI AEROSTRUCTURES INC (CVU) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $19.4M, roughly 1.1× CPI AEROSTRUCTURES INC). CPI AEROSTRUCTURES INC runs the higher net margin — 3.6% vs -20.4%, a 24.0% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -10.8%). Sight Sciences, Inc. produced more free cash flow last quarter ($-2.0M vs $-2.1M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs 0.9%).
CPI Aerostructures Inc., known as CPI Aero, is a contract aircraft component manufacturer based in Edgewood, New York.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
CVU vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $19.4M | $20.4M |
| Net Profit | $691.8K | $-4.2M |
| Gross Margin | 20.3% | 87.3% |
| Operating Margin | 6.4% | -18.0% |
| Net Margin | 3.6% | -20.4% |
| Revenue YoY | -10.8% | 6.9% |
| Net Profit YoY | -28.8% | 64.9% |
| EPS (diluted) | $0.04 | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $19.4M | $20.4M | ||
| Q3 25 | $19.3M | $19.9M | ||
| Q2 25 | $15.2M | $19.6M | ||
| Q1 25 | $15.4M | $17.5M | ||
| Q4 24 | $21.8M | $19.1M | ||
| Q3 24 | $19.4M | $20.2M | ||
| Q2 24 | $20.8M | $21.4M | ||
| Q1 24 | $19.1M | $19.3M |
| Q4 25 | $691.8K | $-4.2M | ||
| Q3 25 | $1.1M | $-8.2M | ||
| Q2 25 | $-1.3M | $-11.9M | ||
| Q1 25 | $-1.3M | $-14.2M | ||
| Q4 24 | $971.5K | $-11.8M | ||
| Q3 24 | $749.7K | $-11.1M | ||
| Q2 24 | $1.4M | $-12.3M | ||
| Q1 24 | $168.2K | $-16.3M |
| Q4 25 | 20.3% | 87.3% | ||
| Q3 25 | 22.3% | 86.4% | ||
| Q2 25 | 4.4% | 84.8% | ||
| Q1 25 | 10.7% | 86.2% | ||
| Q4 24 | 20.0% | 86.8% | ||
| Q3 24 | 21.7% | 83.9% | ||
| Q2 24 | 24.6% | 85.8% | ||
| Q1 24 | 18.6% | 85.5% |
| Q4 25 | 6.4% | -18.0% | ||
| Q3 25 | 9.1% | -39.7% | ||
| Q2 25 | -13.1% | -59.6% | ||
| Q1 25 | -7.7% | -79.2% | ||
| Q4 24 | 9.5% | -62.5% | ||
| Q3 24 | 7.6% | -55.7% | ||
| Q2 24 | 11.2% | -59.2% | ||
| Q1 24 | 4.4% | -76.4% |
| Q4 25 | 3.6% | -20.4% | ||
| Q3 25 | 5.8% | -41.0% | ||
| Q2 25 | -8.7% | -61.0% | ||
| Q1 25 | -8.6% | -80.8% | ||
| Q4 24 | 4.5% | -62.1% | ||
| Q3 24 | 3.9% | -54.9% | ||
| Q2 24 | 6.8% | -57.7% | ||
| Q1 24 | 0.9% | -84.4% |
| Q4 25 | $0.04 | $-0.07 | ||
| Q3 25 | $0.09 | $-0.16 | ||
| Q2 25 | $-0.10 | $-0.23 | ||
| Q1 25 | $-0.10 | $-0.28 | ||
| Q4 24 | $0.08 | $-0.23 | ||
| Q3 24 | $0.06 | $-0.22 | ||
| Q2 24 | $0.11 | $-0.25 | ||
| Q1 24 | $0.01 | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $92.0M |
| Total DebtLower is stronger | $0 | $42.4M |
| Stockholders' EquityBook value | $25.8M | $63.9M |
| Total Assets | $75.2M | $115.3M |
| Debt / EquityLower = less leverage | 0.00× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.0M | ||
| Q3 25 | — | $92.4M | ||
| Q2 25 | — | $101.5M | ||
| Q1 25 | — | $108.8M | ||
| Q4 24 | — | $120.4M | ||
| Q3 24 | — | $118.6M | ||
| Q2 24 | — | $118.2M | ||
| Q1 24 | — | $127.3M |
| Q4 25 | $0 | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | $26.5K | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $25.8M | $63.9M | ||
| Q3 25 | $25.0M | $64.3M | ||
| Q2 25 | $23.8M | $70.0M | ||
| Q1 25 | $24.9M | $77.6M | ||
| Q4 24 | $25.9M | $87.5M | ||
| Q3 24 | $24.9M | $95.0M | ||
| Q2 24 | $24.1M | $101.6M | ||
| Q1 24 | $22.5M | $109.2M |
| Q4 25 | $75.2M | $115.3M | ||
| Q3 25 | $74.1M | $116.3M | ||
| Q2 25 | $72.3M | $122.0M | ||
| Q1 25 | $65.4M | $129.7M | ||
| Q4 24 | $68.0M | $142.8M | ||
| Q3 24 | $68.9M | $143.6M | ||
| Q2 24 | $70.2M | $149.7M | ||
| Q1 24 | $70.8M | $155.6M |
| Q4 25 | 0.00× | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | 0.00× | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.1M | $-1.8M |
| Free Cash FlowOCF − Capex | $-2.1M | $-2.0M |
| FCF MarginFCF / Revenue | -10.8% | -9.7% |
| Capex IntensityCapex / Revenue | 0.0% | 0.8% |
| Cash ConversionOCF / Net Profit | -3.03× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-5.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.1M | $-1.8M | ||
| Q3 25 | $212.1K | $-8.7M | ||
| Q2 25 | $-596.3K | $-7.5M | ||
| Q1 25 | $-2.7M | $-11.6M | ||
| Q4 24 | $4.4M | $-3.5M | ||
| Q3 24 | $715.1K | $362.0K | ||
| Q2 24 | $-591.7K | $-9.5M | ||
| Q1 24 | $-960.5K | $-9.8M |
| Q4 25 | $-2.1M | $-2.0M | ||
| Q3 25 | $211.1K | $-8.9M | ||
| Q2 25 | $-599.8K | $-7.8M | ||
| Q1 25 | $-2.8M | — | ||
| Q4 24 | $4.3M | $-3.6M | ||
| Q3 24 | $586.9K | $311.0K | ||
| Q2 24 | $-746.9K | $-9.5M | ||
| Q1 24 | $-1.0M | $-9.9M |
| Q4 25 | -10.8% | -9.7% | ||
| Q3 25 | 1.1% | -44.7% | ||
| Q2 25 | -4.0% | -39.6% | ||
| Q1 25 | -18.1% | — | ||
| Q4 24 | 19.9% | -18.9% | ||
| Q3 24 | 3.0% | 1.5% | ||
| Q2 24 | -3.6% | -44.7% | ||
| Q1 24 | -5.3% | -51.4% |
| Q4 25 | 0.0% | 0.8% | ||
| Q3 25 | 0.0% | 0.9% | ||
| Q2 25 | 0.0% | 1.1% | ||
| Q1 25 | 0.4% | 0.0% | ||
| Q4 24 | 0.3% | 0.7% | ||
| Q3 24 | 0.7% | 0.3% | ||
| Q2 24 | 0.7% | 0.4% | ||
| Q1 24 | 0.2% | 0.6% |
| Q4 25 | -3.03× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.53× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.42× | — | ||
| Q1 24 | -5.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CVU
| Government Subcontracts | $16.4M | 85% |
| Commercial Contracts | $2.3M | 12% |
| Prime Government Contracts | $725.8K | 4% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
